Ovarian canceris the most malignant of allgynaecological cancers, but patients with disease limited to one ovary and patients with non-epithelial tumours may expect a good prognosis. A selected group of young patients who desire fertility may be well treated with conservative surgery. ...
Ovarian NeoplasmsNeoplasm StagingPrognosisOligonucleotide Array Sequence AnalysisCluster AnalysisSurvival AnalysisGene Expression ProfilingDNA Mutational AnalysisGene Expression Regulation, NeoplasticThe BJC is owned by Cancer Research UK, a charity dedicated to understanding the causes, prevention and treatment of ...
ResearchOpen Access02 Jan 2025 Scientific Reports Volume: 15, P: 596 International multicenter validation of AI-driven ultrasound detection of ovarian cancer In a comprehensive dataset from 3,652 patients across 20 centers in eight countries, an ultrasound-based AI model shows robust performance ac...
Cancer Research UK said that concerning delays to begin treatment in the UK are partly a result of the UK Government's lack of long-term planning on cancer in recent decades. Countries with more robust cancer strategies backed by sufficient funding have seen larger improvements in survival than ...
(Medical Xpress) -- Cancer Research UK’s Drug Development Office has re-launched a trial of a promising drug to treat inherited breast and ovarian cancer – but this time taken as a tablet by outpatients.
NewsOCRA Partners With Microsoft AI Initiative to Accelerate Ovarian Cancer Research NewsLab-Grown 3D Tumor Model Provides New Tool to Study Ovarian Cancer, Treatments NewsLynparza Lowers Risk of Disease Progression in Advanced Ovarian Cancer, 5-year Data Show ...
Cancer is a disease characterized by the uncontrolled multiplication of abnormal cells in the body. There are numerous types of cancers, with certain types being major causes of sickness and death worldwide.
Ovarian cancer is the highest mortality rate of gynecologic cancer disease, one of the most seriously life-threatening malignant cancers in female. Because of the ovaries deep in the pelvis, the early non-specific symptoms,making diagnosis difficult, most patients are diagnosed late already, and cau...
The result of this research is a shift in the “ovarian” cancer paradigm to one that groups cancer of the fallopian tube, peritoneum, and ovary by etiology, molecular and immunohistochemical characteristics, grade, and clinical behavior rather than location. In this paradigm, the fallopian tube ...
Our primary objective was to identify and incorporate additional biomarkers into longitudinal models to improve on the performance of CA125 as a first-line screening test for ovarian cancer. Methods This case–control study nested within UKCTOCS used 490 serial serum samples from 49 women later ...